OTEZLA emballage départ 4x10,4x20,19x30mg 27 pce
7680653460012
CH-65346
L04AA32
07.15.0.
Reimbursement limitations:
OTEZLA3
OTEZLA ne peut être prescrit en combinaison avec des agents biologiques.
OTEZLA ne peut …
1 / 3
google
Details
- Product number
- 6534604
- CPT
- -
- Packaging group
- 4 + 4 + 19
- Unit
- Tablette(n)
- Composition
- I) 10 mg: apremilastum 10 mg, cellulosum microcristallinum, lactosum monohydricum 60 mg, carmellosum natricum conexum corresp. natrium 0.56 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), pro compresso obducto. II) 20 mg: apremilastum 20 mg, cellulosum microcristallinum, lactosum monohydricum 120 mg, carmellosum natricum conexum corresp. natrium 1.12 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. III) 30 mg: apremilastum 30 mg, cellulosum microcristallinum, lactosum monohydricum 180 mg, carmellosum natricum conexum, natrium 1.68 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), pro compresso obducto.
Articles (1)
Otezla 10 mg, 20 mg, 30 mg, Filmtabletten
Filmtabletten
4 + 4 + 19
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
III
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
I
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
60.0 MG | Substance | HBESI |
|
II
|
120.0 MG | Substance | HBESI |
|
III
|
180.0 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
1.12 MG | Substance | HBESI |
|
III
|
1.68 MG | Substance | HBESI |
|
I
|
0.56 MG | Substance | HBESI |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | FNIDK |
|
I
|
- | Substance | FNIDK |
|
II
|
- | Substance | FNIDK |
|
I
|
- | Substance | FTODK |
|
III
|
- | Substance | FTODK |
|
II
|
- | Substance | FTODK |
|
II
|
- | Substance | FTODK |
|
III
|
- | Substance | FTODK |
|
III
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 317.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2015
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65346
- Drug name
- Otezla, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L04AA32
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/07/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OTEZLA emballage départ 4x10,4x20,19x30mg 27 pce
- Description (DE)
- OTEZLA Starterpackung 4x10,4x20,19x30mg 27 Stk
- Market launch
- 21/07/2015
- Narcotic (BTM)
- No